Press release
Global Metabolomics Biomarker Market Research and Forecast 2018-2023
According to the OMR analysis, the global metabolomics biomarker market is growing at a significant rate during 2018-2023. Metabolomics are profiling of metabolites in biofluids, cells and tissues, which are routinely applied as a tool for biomarker discovery. Due to innovation and developments in informatics and analytical technologies, enables in expanding metabolomic analyses and to understand the systems-level effects of metabolites. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.
Full report of global high metabolomics biomarker market is available at: https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market/
Metabolomics enables in advance the current understanding, diagnosis and treatment of several health conditions, which includes cancer, cardiovascular and neurological disorder. It enables in identifying pathophysiological processes and mechanisms of disease and management of targeted disease. The metabolomics biomarkers in tissue samples or biopsies, categorize and stage the progression of cancers, which enables in making appropriate decisions for treatment. The extensive application of metabolomics biomarker in colorectal cancer detection is driving the metabolomics biomarker market. The abnormal growth of cells in colon or rectum causes colorectal cancer, which is third commonly diagnosed cancer. According to American cancer society, about 27,150 men and 23,110 women died from Colorectal cancer in 2017. It is estimated about 95,520 new cases of colon cancer and 39,910 cases of rectal cancer diagnosed in US.
The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is expected to dominate the metabolomics biomarker market and have the highest market share during the forecast period 2018-2023. Due to high product commercialization rates, development in healthcare sector and increasing use of biomarkers in drug discovery and development enables in boosting metabolomics biomarker market. Asia-Pacific shows high growth rate in metabolomics biomarker market due to increasing demand for improved pharmaceutical products, which are generated from emerging economies such as India and China, are significant contributing in the growth of the market.
The report covers:
Comprehensive research methodology of global metabolomics biomarker market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global metabolomics biomarker market.
Insights about market determinants which are stimulating the global metabolomics biomarker market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
For related reports please visit: https://www.omrglobal.com/reports-category/biotechnology/
For more updates follow LinkedIn: www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Metabolomics Biomarker Market Research and Forecast 2018-2023 here
News-ID: 1342017 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Metabolomics
Emerging Trends Influencing The Growth Of The Metabolomics Services Market: Inno …
The Metabolomics Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Metabolomics Services Market Size Expected to Be by 2034?
The metabolomics services market size will grow from $2.65 billion in 2024 to $3.04 billion in 2025 at a compound annual growth…
Major Market Shift in Metabolomics Services Industry: Innovative Diagnostic Tool …
"What Is the Forecasted Market Size and Growth Rate for the Metabolomics Services Market?
The scale of the metabolomics services market has rapidly expanded in the last few years. It is projected to surge from $2.65 $ billion in 2024 to $3.04 $ billion in 2025, representing a compound annual growth rate (CAGR) of 14.7%. This growth during the historical span is the result of a greater emphasis on biomarker discovery,…
Coverage: Metabolomics Market covers analysis By Products and Services (Metabolo …
Metabolomics is the study of small molecules which resides in cells, biofluids, and tissues. The studies are extensively conducted with an aim to analyze biochemical activities of these small molecules and their interactions with biological systems. Metabolomics has wide variety of applications in disease diagnosis, drug discovery, enzyme discovery, and others.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00008670?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Thermo Fisher Scientific Inc.
Waters Corporation
Agilent Technologies, Inc.
Human Metabolome Technologies, Inc.
Bruker Corporation
Shimadzu Corporation
PerkinElmer
Metabolon, Inc.
Leco Corporation
Hitachi…
Metabolomics Market: Partnerships and investments to speed up development of met …
In the field of precision medicine, metabolomics has been playing a crucial part and emerging as a vital tool. The analysis of metabolites such as amino acids, sugars, and lipids within biological systems can be utilized for diagnosing various types of diseases such as cancer, depression, and others. Market players have adopted various strategies such as partnership and raising funding to accelerate the development of products.
Request Sample Report at:…
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more…
Metabolomics Market : Future of Metabolomics Dependent on Biomarker Discovery an …
According to a new market report published by Transparency Market Research “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024”, the metabolomics market is anticipated to expand at a CAGR of 17.1% from 2016 to 2024 to reach USD 2,494.8 million by 2024.
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules…
